Funded Tech Companies

Precirix

Headquartered in Brussels, Precirix is venture-backed, with investment from Pontifax Fund, Novo Ventures and V-Bio Ventures.

Company Overview

Contact Information

Company Background Information

Overview

PRECIRIX® is a clinical-stage biotechnology company dedicated to improving the lives of cancer patients by developing novel targeted radiopharmaceuticals using camelid single domain antibody fragments.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

3/24/2022

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Ruth Devenyns

        

Chief Scientific Officer

Tony Lahoutte

        

Chief Technical Officer

Niva Almaula

        

VP - Bus. Development

Niva Almaula

        

Company Investors

• Pontifax Fund (Ohad Hammer)
• Novo Ventures (Morten Døssing)
• V-Bio Ventures (Christina Takke)
• Healthcap Venture Capital (Mårten Steen)
• BioMedPartners
• GIMV (Karl Naegler)
• BioMed Ventures
• JEITO (Sabine Dandiguian)
• Forbion Capital Partners (Jasper Bos)
• INKEF Capital (Simone Botti)

Browse more funded tech companies:

PreciPoint | Precise Light Surgical

Share this article

About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary